Betalin Therapeutics is a preclinical stage company developing an innovative therapy for diabetes treatment. This game changing technology aims to replace insulin therapy for millions of patients worldwide.
The Betalin Therapeutics team of leading experts in the fields of diabetes and biotechnology development are based at the Hebrew University-Hadassah Medical Center campus where EMP technology was first discovered.
Today diabetes management requires a combination of medications and lifestyle changes. This is a physical, emotional and financial burden on millions of people with diabetes and their caregivers.
Betalin Therapeutics is developing a cutting edge solution for diabetes. Contact us to find out how you can be a part of this exciting journey.
Betalin Therapeutics is currently in the pre-clinical phase and is not recruiting patients for clinical trials. If you are interested in participating in clinical trials in the future, watch this space for updates.